Dialysis disequilibrium syndrome: Difference between revisions
No edit summary
Line 43: Line 43:


==Evaluation==
==Evaluation==
*Clinical Diagonosis
===Workup===
*Bedside Glucose
*Bedside Glucose
*CBC
*CBC
Line 50: Line 50:
*CT Brain
*CT Brain


==Workup==
===Diagnosis===
*Diagnosis suggested by development of neurologic symptoms associated with dialysis, however DDS is a diagnosis of exclusion (rule out [[SDH]], [[CVA]]).
*Is a clinical diagnosis, suggested by development of neurologic symptoms associated with dialysis
**However, must first exclude more serious diagnoses (rule out [[SDH]], [[CVA]]).


==Management==
*Symptomatic management for mild symptoms (nausea, headache, restlessness)
**Symptoms are self-limiting and typically resolve within several hours
*For severe symptoms, the mainstay of treatment is ICP reduction<ref name="DDS"></ref>
**Can give [[mannitol]] or [[hypertonic saline]] IV
**Can hyperventilate patient
==Disposition==
*Depends on severity
**Many cases can be discharged with followup


==Management==
==Prevention==
===Prevention===
*Response to treatment is typically poor, so preventive measures are important<ref name="DDS"></ref>
*Response to treatment is typically poor, so preventive measures are important<ref name="DDS"></ref>
*Add an osmotic agent to mitigate the osmotic gradient
*Add an osmotic agent to mitigate the osmotic gradient
Line 61: Line 71:
**Elevate the glucose concentration in the diasylate (717 mg/dl) or add IV mannitol (1g/kg)<ref>Rodrigo F. et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554-61. [http://www.ncbi.nlm.nih.gov/pubmed/851303/ Pubmed]</ref>
**Elevate the glucose concentration in the diasylate (717 mg/dl) or add IV mannitol (1g/kg)<ref>Rodrigo F. et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554-61. [http://www.ncbi.nlm.nih.gov/pubmed/851303/ Pubmed]</ref>
*Consider hemofiltration rather than hemodialysis<ref>Kishimoto T. et al. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artif Organs. 1980;4(2):86-93. [http://www.ncbi.nlm.nih.gov/pubmed/7396769/ Pubmed]</ref>
*Consider hemofiltration rather than hemodialysis<ref>Kishimoto T. et al. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artif Organs. 1980;4(2):86-93. [http://www.ncbi.nlm.nih.gov/pubmed/7396769/ Pubmed]</ref>
===Treatment===
*The mainstay of treatment is ICP reduction<ref name="DDS"></ref>
**Can give [[mannitol]] or [[hypertonic saline]] IV
**Can hyperventilate patient
*Symptomatic management for mild symptoms (nausea, headache, restlessness)
*Symptoms are self-limiting and typically resolve within several hours
==Management==
*Supportive in most cases
*Limit the rate of urea removal during first few session of dialysis to prevent dysequilibrium syndrome
*For severe symptoms such as seizure, consider stopping dialysis
==Disposition==
*Most cases can be discharged with followup


==See Also==
==See Also==

Revision as of 10:18, 27 April 2017

Background

  • Abbreviation: DDS
  • A rare clinical syndrome occurring at end of dialysis or the beginning of continuous renal replacement therapy
    • Occurs most commonly during initial hemodialysis or during hypercatabolic states
    • Tends to occur in patients who are initially started on dialysis, particularly with high initial BUN
    • Symptoms are thought to be secondary to the development of cerebral edema possibly due to urea removal during dialysis and from a decreased in pH in the cerebral intracelluar environment
  • Large and rapid solute clearance creates an osmotic gradient which can precipitate cerebral edema [1]
    • Pre-dialysis urea in CSF lower than in blood[2]
    • Post-dialysis urea in CSF higher, setting up osmotic gradient for water into CNS
    • More uremic patients pre-dialysis at higher risk

Clinical Features

Signs and symptoms develop during or after dialysis or during renal replacement therapy, usually self limited but can occasionally progress

Differential Diagnosis

Dialysis Complications

Evaluation

Workup

  • Bedside Glucose
  • CBC
  • Chem-10
  • Liver Panel
  • CT Brain

Diagnosis

  • Is a clinical diagnosis, suggested by development of neurologic symptoms associated with dialysis
    • However, must first exclude more serious diagnoses (rule out SDH, CVA).

Management

  • Symptomatic management for mild symptoms (nausea, headache, restlessness)
    • Symptoms are self-limiting and typically resolve within several hours
  • For severe symptoms, the mainstay of treatment is ICP reduction[3]

Disposition

  • Depends on severity
    • Many cases can be discharged with followup

Prevention

  • Response to treatment is typically poor, so preventive measures are important[3]
  • Add an osmotic agent to mitigate the osmotic gradient
    • Elevate the sodium concentration in the diasylate[5]
    • Elevate the glucose concentration in the diasylate (717 mg/dl) or add IV mannitol (1g/kg)[6]
  • Consider hemofiltration rather than hemodialysis[7]

See Also

References

  1. ↑ Silver SM. et al. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect". Kidney Int. 1992;42(1):161-6. Pubmed
  2. ↑ Zepeda-Orozco D and Quigley R. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012 Dec; 27(12): 2205–2211.
  3. ↑ 3.0 3.1 3.2 3.3 Zepeda-orozco D. et al. Dialysis disequilibrium syndrome. Pediatr Nephrol. 2012;27(12):2205-11.Pubmed
  4. ↑ Mahoney CA. et al. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2(3):324-36. Pubmed
  5. ↑ Port FK. et al. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int. 1973;3(5):327-33.Pubmed
  6. ↑ Rodrigo F. et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554-61. Pubmed
  7. ↑ Kishimoto T. et al. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artif Organs. 1980;4(2):86-93. Pubmed
Retrieved from "https://www.wikem.org/w/index.php?title=Dialysis_disequilibrium_syndrome&oldid=132723"